TY - JOUR
T1 - Pulmonary hypertension with bronchopulmonary dysplasia
T2 - Aichi cohort study
AU - Kawai, Yuri
AU - Hayakawa, Masahiro
AU - Tanaka, Taihei
AU - Yamada, Yasumasa
AU - Nakayama, Atsushi
AU - Kato, Yuichi
AU - Kouwaki, Masanori
AU - Kato, Takenori
AU - Tanaka, Ryo
AU - Muramatsu, Kanji
AU - Hayashi, Seiji
AU - Yamamoto, Hikaru
AU - Takemoto, Koji
AU - Ieda, Kuniko
AU - Nagaya, Yoshiaki
AU - Honda, Shigeru
AU - Shinohara, Osamu
AU - Funato, Yusuke
AU - Kokubo, Minoru
AU - Imamine, Hiroki
AU - Miyata, Masafumi
N1 - Publisher Copyright:
© 2022 Japan Pediatric Society.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Background: The incidence of pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) has not been investigated in regional cohorts. The aim of this study was to clarify the incidence of PH associated with BPD in all very low birthweight infants (VLBWIs) born during the study period in Aichi Prefecture, Japan. Methods: We conducted a retrospective observational cohort study of all VLBWIs born in Aichi Prefecture. The inclusion criteria were VLB, birth between 1 January 2015 and 31 December 2015, and admission to any neonatal intensive care unit in Aichi Prefecture. BPD28d and BPD36w were defined as the need for supplemental oxygen or any respiratory support at 28 days of age or 36 weeks of postmenstrual age (PMA). The primary outcome was the incidence of PH after 36 weeks’ PMA (PH36w) in VLBWIs with BPD28d and BPD36w. The secondary outcomes were the clinical factors related to PH36w in BPD36w patients. Mann–Whitney U-test and Fisher’s exact test were used for univariate analysis. Differences were considered statistically significant at P < 0.05. Risk ratio (RR) and 95% confidence interval (CI) were also evaluated. Results: A total of 441 patients were analyzed. A total of 217 and 131 patients met the definition of BPD28d and BPD36w, respectively. Nine patients were diagnosed with PH36w (4.2% and 6.9% of the BPD28d and BPD36w patients, respectively). The presence of oligohydramnios (RR, 2.71; 95% CI: 1.55–4.73, P = 0.014) and sepsis (RR, 3.62; 95% CI: 1.51–8.63, P = 0.025) was significant in the PH36w patients. Conclusions: The incidence of PH36w was 4.2% and 6.9% in the BPD28d and BPD36w patients, respectively. Oligohydramnios and sepsis were significantly associated with PH36w in VLBWIs.
AB - Background: The incidence of pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) has not been investigated in regional cohorts. The aim of this study was to clarify the incidence of PH associated with BPD in all very low birthweight infants (VLBWIs) born during the study period in Aichi Prefecture, Japan. Methods: We conducted a retrospective observational cohort study of all VLBWIs born in Aichi Prefecture. The inclusion criteria were VLB, birth between 1 January 2015 and 31 December 2015, and admission to any neonatal intensive care unit in Aichi Prefecture. BPD28d and BPD36w were defined as the need for supplemental oxygen or any respiratory support at 28 days of age or 36 weeks of postmenstrual age (PMA). The primary outcome was the incidence of PH after 36 weeks’ PMA (PH36w) in VLBWIs with BPD28d and BPD36w. The secondary outcomes were the clinical factors related to PH36w in BPD36w patients. Mann–Whitney U-test and Fisher’s exact test were used for univariate analysis. Differences were considered statistically significant at P < 0.05. Risk ratio (RR) and 95% confidence interval (CI) were also evaluated. Results: A total of 441 patients were analyzed. A total of 217 and 131 patients met the definition of BPD28d and BPD36w, respectively. Nine patients were diagnosed with PH36w (4.2% and 6.9% of the BPD28d and BPD36w patients, respectively). The presence of oligohydramnios (RR, 2.71; 95% CI: 1.55–4.73, P = 0.014) and sepsis (RR, 3.62; 95% CI: 1.51–8.63, P = 0.025) was significant in the PH36w patients. Conclusions: The incidence of PH36w was 4.2% and 6.9% in the BPD28d and BPD36w patients, respectively. Oligohydramnios and sepsis were significantly associated with PH36w in VLBWIs.
UR - http://www.scopus.com/inward/record.url?scp=85136044973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136044973&partnerID=8YFLogxK
U2 - 10.1111/ped.15271
DO - 10.1111/ped.15271
M3 - Article
C2 - 35972055
AN - SCOPUS:85136044973
SN - 1328-8067
VL - 64
JO - Pediatrics International
JF - Pediatrics International
IS - 1
M1 - e15271
ER -